U.S. Insurance Stock News

ORIC Pharmaceuticals (ORIC) just released detailed Phase 1b data for its prostate cancer drug candidate rinzimetostat with darolutamide, and selected a 400 mg daily dose for a planned global Phase 3 Himalayas 1 trial. See our latest analysis for ORIC Pharmaceuticals. The latest clinical update has come during a volatile stretch for ORIC, with a 1 day share price return of 18.93% following a 7 day share price return decline of 26.29% and a 30 day share price return decline of 35.16%. The 1...

In late March 2026, BrightSpring Health Services reported quarterly revenue that exceeded analyst expectations and issued guidance implying continued strong revenue growth, while also announcing the resignation of Robert Barnes, President of ResCare Community Living, which the company said was not due to any disagreement over operations or policies. Beyond the headline earnings beat, BrightSpring’s recent results highlight its ability to grow revenue at scale, reinforcing its position in...

In recent months, GDS Holdings launched a China Real Estate Investment Trust to recycle data center assets into cash for AI-focused infrastructure, while institutional investors such as Baron Capital and hedge fund manager Rob Citrone increased their positions as management emphasized strong AI-driven order expectations. What stands out is how GDS is using the C-REIT structure not just to raise funds, but to potentially upgrade its asset mix toward higher-value AI capacity while keeping...

In recent days, Helix Energy Solutions Group reported fourth-quarter results with revenue slightly lower year on year but materially ahead of analyst expectations on EPS and EBITDA, while also securing a multi-year well plug and abandonment program in the UK North Sea. At the same time, rising crude prices amid heightened U.S.–Iran tensions have drawn attention to how geopolitical risk can influence demand for Helix’s offshore services and earnings potential. We’ll now examine how Helix’s...

In recent weeks, Melco Resorts & Entertainment reported mixed fourth-quarter 2025 results, while major banks including BofA Securities, UBS, and Morgan Stanley updated their research views on the company amid concerns over liquidity, margins, and Macau market conditions. At the same time, Melco underscored its premium positioning by highlighting eight MICHELIN Stars across five Macau restaurants, reinforcing how high-end non-gaming offerings are becoming a central part of its hospitality and...

Voya Financial (VOYA) has brought the administration of Leave, Paid Family and Medical Leave, and Short-Term Disability claims in house for new business, integrating these services with its supplemental health and life insurance offerings. See our latest analysis for Voya Financial. Voya’s move to bring leave and disability claims in house comes after a weaker patch for the stock, with a 90 day share price return decline of 13.08% but a 1 year total shareholder return of 21.83%. This...

Recent performance snapshot Hayward Holdings (HAYW) has quietly shifted in recent months, with the share price around US$13.38 after a slight 1 day pullback and mixed moves over the past week and month. See our latest analysis for Hayward Holdings. The recent 10% one-month share price decline and 16% weaker 90-day share price return contrast with a 9.67% one-year total shareholder return, suggesting that near-term momentum has cooled even as longer-term holders still show a gain. If Hayward...

Aflac (AFL) has drawn attention after Aflac Re Bermuda agreed to reinsure a block of whole life annuities from Japan Post Insurance through coinsurance, while also rolling out a new long term care focused life product. See our latest analysis for Aflac. Aflac’s recent reinsurance deal in Japan and new long term care life product in the U.S. come as the share price sits at US$110.48, with a 7 day share price return of 3.82% but a slightly negative 90 day share price return, while longer term...

Recent share performance and business snapshot Azenta (AZTA) has drawn attention after a recent 1 day share move of 6.8%, capping a week where the stock returned 13.7%, despite negative returns over the month and past 3 months. The company, valued at about US$1.0b with a last close of US$22.63, focuses on biological and chemical sample management and multiomics services across the United States, Europe, Asia Pacific, and China. See our latest analysis for Azenta. The recent 1 day share price...

Guidewire Software (GWRE) is back in focus after Belgian insurer Ethias went live on Guidewire Cloud Platform, a client milestone that underscores adoption of the company’s cloud based core systems and AI ready infrastructure. See our latest analysis for Guidewire Software. The Ethias go live comes after a period of mixed momentum, with the share price at US$150.79, a 7 day share price return of 4.22%, a 90 day share price return of 18.90%, and a 1 year total shareholder return of 13.46%. The...

In early April 2026, Kroger came under renewed focus after former merger partner Albertsons announced store closures and layoffs as part of a restructuring amid fierce grocery competition from large national and regional chains. At the same time, Kroger has been pushing seasonal promotions and reported improved profitability and cash generation, underscoring how retailers are relying on both sharper pricing and efficiency gains to compete. We’ll now examine how heightened competitive...

Why Evergy’s latest milestones matter for income-focused investors Evergy (EVRG) is drawing fresh attention after extending its 23-year streak of dividend increases, signing new data center power agreements, and using its BBB+ credit rating to support a sizable five-year investment program. See our latest analysis for Evergy. At a share price of $82.84, Evergy’s recent 14.56% 90 day share price return and 29.90% 1 year total shareholder return suggest momentum has been rebuilding after a...

In the past quarter, Ingersoll Rand reported revenues of US$2.09 billion, a 10.1% year-on-year increase that exceeded analyst expectations by 2.6%, alongside stronger earnings and free cash flow in what management called a complex global backdrop. At the same time, insider sentiment turned more cautious with increased insider selling, even as Barclays reaffirmed its positive view on the company’s operational performance. We’ll now examine how this stronger-than-expected revenue performance...

In recent weeks, conflict at Mexico City International Airport has intensified as the National Guard detained and impounded vehicles of DiDi and other ride-hailing drivers, despite existing judicial injunctions meant to protect them. This clash, unfolding as Mexican authorities form a working group to craft new rules ahead of the 2026 FIFA World Cup, highlights how regulatory uncertainty at a key transport hub could affect DiDi’s service reliability and user experience in an important...

In early April 2026, IDEXX Laboratories launched its IDEXX Cancer Dx Panel for early lymphoma detection in at-risk dogs across UK veterinary practices, offering blood-based screening that integrates into existing wellness and diagnostic workflows with results delivered in 3–5 business days. This launch not only broadens IDEXX’s preventative care portfolio but also taps into strong pet-owner interest in cancer screening and builds on early adoption of the test by thousands of clinics in North...

Morgan Stanley’s upgrade of Lemonade (LMND), tied to its new Tesla auto insurance partnership, has pulled fresh attention to the insurer’s AI focus as investors reassess the stock after a volatile few months. See our latest analysis for Lemonade. The Tesla tie up and South Carolina renters launch come after a sharp rebound, with a 21% share price gain in March and a 1 year total shareholder return of 118.21% following earlier weakness. Momentum has picked up despite a 19.08% year to date...

Event driven snapshot for PBF Energy (PBF) PBF Energy (PBF) shares recently closed at US$45.39 after a 1-day return of a 1.52% decline and a 7-day return of an 11.40% decline, putting recent volatility front and center for investors watching the refiner. See our latest analysis for PBF Energy. While the recent 7 day share price return of an 11.40% decline signals fading short term momentum, the 90 day share price return of 53.86% and 1 year total shareholder return of 214.74% still point...

Understanding Penguin Solutions after its recent rebrand Penguin Solutions (PENG) recently changed its name from SMART Global Holdings, a shift that brings its high performance computing, AI infrastructure, memory, and LED businesses together under a single, clearer identity for investors to evaluate. See our latest analysis for Penguin Solutions. The recent rebrand has arrived alongside sharp near term share price momentum, with a 1 day share price return of 13.37% and 7 day share price...

Live Oak Bancshares (LOB) has drawn investor attention after reporting 16.8% year on year revenue growth that topped expectations, while missing EPS and tangible book value estimates. This mix coincided with a sharp share price drop. See our latest analysis for Live Oak Bancshares. Beyond the immediate earnings reaction, Live Oak Bancshares’ share price at US$33.39 sits below its recent highs. It has a 7 day share price return of 4.05%, a 90 day share price return decline of 6.63%, while the...

In recent weeks, Modine Manufacturing reported earnings that exceeded market expectations, accompanied by heightened interest from large institutional investors and sustained analyst optimism around its thermal solutions business. Beyond financial results, the company’s pivot toward AI-focused liquid cooling and its participation in the U.S. Department of Energy’s Better Plants program highlight how its growth ambitions are increasingly tied to energy efficiency and data center...

In March 2026, Clarivate Plc released the Clarivate AI50, a data-driven benchmark ranking 50 leading organizations in high-impact artificial intelligence inventions, built on its Derwent World Patents Index and Strength Index analytics. The report highlights how AI innovation is clustering in a few countries and sectors, with government and academic institutions playing an outsized role in advancing foundational research and cross-border collaboration. We’ll now examine how this new AI50...

In recent weeks, ADMA Biologics has come under scrutiny as multiple law firms launched securities fraud investigations following a short-seller report alleging inflated revenue, channel stuffing, and undisclosed related-party sales tied to its plasma-derived therapies. This wave of legal and reputational pressure raises pointed questions about the reliability of ADMA’s reported growth and the sustainability of its current business practices. We’ll now examine how these channel-stuffing and...

In early April 2026, Superpower announced a partnership with GRAIL, Inc. to offer the Galleri multi-cancer early detection blood test through its preventative health platform, giving members nationwide access to screening for signals across more than 50 cancer types with integrated clinical support. By embedding Galleri into a broader biomarker and AI-driven care model for both individuals and employer populations, the collaboration positions GRAIL’s test as part of a comprehensive early...

Why Yum China’s 2026 proxy filing matters for shareholders Yum China Holdings (YUMC) has put its 2026 annual meeting in motion with a preliminary proxy filing that sets up shareholder votes on the board, executive pay, auditor choice, share issuance, and potential buybacks. See our latest analysis for Yum China Holdings. Against this proxy backdrop, Yum China’s recent share price performance has been mixed, with a 5.1% decline over the past month but a 4.99% 3 month share price return and a...